Genetic variability in MHC genes [1], as well as dynamic changes in their expression level [2,3,4], can affect many diseases, such as cancer and infectious or autoimmune diseases, among others, and these MHC-presented peptides could play a key role in disease progression [5]. Here, HLA-C is linked to cancer.